This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2007 Jun 23;151(25):1435; author reply 1435-6.

[Immunomodulatory therapy in multiple sclerosis]

[Article in Dutch]

B M J Uitdehaag, B Jelles, J Killestein, B W van Oosten, C H Polman

PMID: 17668612

Comment

[Immunomodulatory therapy in multiple sclerosis]

[Article in Dutch]

B M J Uitdehaag et al. Ned Tijdschr Geneeskd. 2007.

. 2007 Jun 23;151(25):1435; author reply 1435-6.

Authors

B M J Uitdehaag, B Jelles, J Killestein, B W van Oosten, C H Polman

PMID: 17668612

No abstract available

PubMed Disclaimer

Comment on

[Still no evidence on the efficacy of immunomodulatory therapy in reducing functional impairment in multiple sclerosis].
Vermeulen M. Vermeulen M. Ned Tijdschr Geneeskd. 2007 Apr 14;151(15):850-1. Ned Tijdschr Geneeskd. 2007. PMID: 17472114 Dutch.
[Natalizumab in multiple sclerosis: unclear patient benefits].
Schipper JP. Schipper JP. Ned Tijdschr Geneeskd. 2007 Apr 14;151(15):852-5. Ned Tijdschr Geneeskd. 2007. PMID: 17472115 Review. Dutch.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information